Scholarlink

<p>Parkinson’s disease (PD) arises from the loss of nigrostriatal dopamine (DA) neurons in the substantia nigra pars compacta (SNc) precipitating motor impairments such as tremor, rigidity, and akinesia. DA replacement therapy via levodopa (L-DOPA), though effective, often results in the development of levodopa-induced-dyskinesia (LID), characterized by excessive hyperkinetic choreic and dystonic movements. While a myriad of mechanisms are implicated in LID, maladaptive neuroplasticity within raphe-striatal serotonin (5-HT) neurons appear to influence LID induction and severity. Although prior work has established a link between the 5-HT system and LID, tools utilized have been limited and the mechanism(s) remains elusive. Thus, the current set of experiments implemented a chemogenetic strategy by employing inhibitory DREADD (designer receptors exclusively activated by designer drugs) hM4Di expression specifically in 5-HT neurons of the DRN of hemi-parkinsonian TPH2-CRE transgenic rats, followed by chronic L-DOPA treatment. To assess the influence of DRN 5-HT inhibition on established LID, DREADD ligand C21 (0, 0.5, 3, 6&#xa0;mg/kg, i.p.) was systemically administered in a within-subjects design in Experiment 1. In Experiment 2, we administered C21 (0, 0.1, 1.0&#xa0;mM) directly into the DA-lesioned striatum via reverse in vivo microdialysis to determine if local DREADD-mediated 5-HT terminal inhibition per se, altered established LID. Results revealed C21 suppressed LID systemically (Experiment 1) and intrastriatally (Experiment 2) as well as reduced L-DOPA-induced striatal DA release. Post-mortem analyses revealed that nigrostriatal denervation alongside L-DOPA resulted in striatal reorganization of 5-HT innervation, highlighting a key component of raphe-striatal dysfunction in the expression of LID.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of chemogenetic inhibition of serotonergic raphe-striatal neurons on L-DOPA-induced behaviors and neurochemistry in a rat model of Parkinson’s disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月11日

查看全文
  • Carla N. Budrow,
  • Luis-Daniel Bernal-Conde,
  • Ivette M. Sandoval,
  • Ashley Galfano,
  • Han Grezenko,
  • Angela Velazquez,
  • David J. Marmion,
  • Eden Flores-Barrera,
  • Shruti Venkatesh,
  • Michael Coyle,
  • Kimberly Meyers,
  • Kayla Nguyen,
  • Hannah Holden,
  • Kuei Yuan Tseng,
  • Christopher R. Bishop,
  • Fredric P. Manfredsson

摘要

Parkinson’s disease (PD) arises from the loss of nigrostriatal dopamine (DA) neurons in the substantia nigra pars compacta (SNc) precipitating motor impairments such as tremor, rigidity, and akinesia. DA replacement therapy via levodopa (L-DOPA), though effective, often results in the development of levodopa-induced-dyskinesia (LID), characterized by excessive hyperkinetic choreic and dystonic movements. While a myriad of mechanisms are implicated in LID, maladaptive neuroplasticity within raphe-striatal serotonin (5-HT) neurons appear to influence LID induction and severity. Although prior work has established a link between the 5-HT system and LID, tools utilized have been limited and the mechanism(s) remains elusive. Thus, the current set of experiments implemented a chemogenetic strategy by employing inhibitory DREADD (designer receptors exclusively activated by designer drugs) hM4Di expression specifically in 5-HT neurons of the DRN of hemi-parkinsonian TPH2-CRE transgenic rats, followed by chronic L-DOPA treatment. To assess the influence of DRN 5-HT inhibition on established LID, DREADD ligand C21 (0, 0.5, 3, 6 mg/kg, i.p.) was systemically administered in a within-subjects design in Experiment 1. In Experiment 2, we administered C21 (0, 0.1, 1.0 mM) directly into the DA-lesioned striatum via reverse in vivo microdialysis to determine if local DREADD-mediated 5-HT terminal inhibition per se, altered established LID. Results revealed C21 suppressed LID systemically (Experiment 1) and intrastriatally (Experiment 2) as well as reduced L-DOPA-induced striatal DA release. Post-mortem analyses revealed that nigrostriatal denervation alongside L-DOPA resulted in striatal reorganization of 5-HT innervation, highlighting a key component of raphe-striatal dysfunction in the expression of LID.